CLINICAL TRIALS PROFILE FOR SECRETIN
✉ Email this page to a colleague
All Clinical Trials for secretin
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT00036231 ↗ | Synthetic Human Secretin in Children With Autism and Gastrointestinal Dysfunction | Terminated | Repligen Corporation | Phase 3 | 2002-04-01 | The purpose of the study is to determine the effect of multiple doses of secretin on autism. |
NCT00036244 ↗ | Synthetic Human Secretin in Children With Autism | Completed | Repligen Corporation | Phase 3 | 2002-04-01 | The purpose of the study is to determine whether multiple doses of secretin are safe and effective in the treatment of children with autism. |
NCT00065962 ↗ | Secretin for the Treatment of Autism | Completed | National Institute on Deafness and Other Communication Disorders (NIDCD) | Phase 3 | 1999-06-01 | Many drugs used to treat autism target specific symptoms, such as hyperactivity and aggressiveness. Few drugs target the core autistic symptoms of impaired social interaction and communication. This study will evaluate two forms of the drug secretin for the treatment of core autistic symptoms. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for secretin
Condition Name
Clinical Trial Locations for secretin
Trials by Country
Clinical Trial Progress for secretin
Clinical Trial Phase
Clinical Trial Sponsors for secretin
Sponsor Name